-
OM-MSCs Reduce Golgi Stress After Cerebral IRI
2026-10-01
The reference study identifies a mechanistic link between olfactory mucosa mesenchymal stem cells, PEDF secretion, and suppression of Golgi apparatus stress after cerebral ischemia/reperfusion injury. Its cell and rat experiments indicate that PEDF-associated activation of PI3K/Akt/mTOR signaling reduces oxidative and calcium stress, Golgi fragmentation, and excessive autophagy.
-
Amitriptyline HCl: Practical Research Workflow
2026-10-01
This dossier-led guide provides an actionable workflow for preparing and evaluating Amitriptyline HCl (SKU B2231) in receptor, signaling, and exploratory neuropharmacology assays. It is intended for controlled in vitro research and model-system experiments, not as evidence of clinical efficacy, disease-model validation, or a universal activity constant.
-
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-09-30
Xiao et al. identify CH25H and lysosomal 25-hydroxycholesterol as an immunometabolic checkpoint that links macrophage cholesterol handling to AMPKα–STAT6 signaling and ARG1 production. The study also shows that CH25H targeting can improve T-cell surveillance and enhance anti-PD-1 responses, providing a mechanistic framework for studying immunosuppressive tumor-associated macrophages.
-
HATU for Peptide Coupling and IRAP Inhibitor Design
2026-09-30
HATU combines rapid carboxylic acid activation with a practical workflow for assembling peptide-like IRAP inhibitor analogues. This guide connects coupling conditions, stereochemical control, assay design, and troubleshooting to the structure-guided findings of a selective nanomolar inhibitor study.
-
ICI 118,551 Hydrochloride: β2-AR Tool
2026-09-29
ICI 118,551 hydrochloride is a selective β2-adrenoceptor antagonist used to test ADRB2-dependent signaling. It should not be identified with esculetin or treated as evidence for the CKLF1-mediated stroke mechanism reported in a separate mouse study.
-
Tyrothricin Workflows for Antimicrobial Research
2026-09-29
Tyrothricin is a peptide antibiotic mixture suited to membrane-focused antimicrobial assays, from bacterial viability testing to exploratory fungal and enveloped-virus workflows. This guide converts its membrane-disruptive activity into practical experimental steps, controls, optimization logic, and time-resolved assay design.
-
Reactive Oxygen Species Assay Kit for Superoxide
2026-09-28
Track intracellular superoxide during redox-targeted experiments without treating all ROS as one signal. This practical guide shows how to use DHE fluorescence to investigate TrxR–MAPK research, while flagging controls and interpretation limits that matter in tumor-immunity models.
-
Esculetin limits neutrophil infiltration after stroke
2026-09-27
In a mouse photothrombotic stroke model, esculetin reduced injury and improved behavioral and functional MRI measures while suppressing CKLF1–CCR5-associated neutrophil recruitment. The results identify a pathway-dependent preclinical mechanism for esculetin, but do not establish clinical efficacy or a human treatment regimen.
-
CDK8/19 Inhibition and Osteoarthritis Findings
2026-09-26
A 2026 Bone Research study reports that CDK8/19 inhibition affects chondrocyte hypertrophy, inflammatory responses, and cartilage matrix maintenance, with functional and structural improvements in STR/Ort mice. Its integrated cell, human-tissue, and animal experiments broaden assessment beyond cartilage lesion scores, while leaving questions about target specificity and translation to human disease.
-
Deferasirox and Ferroptosis: Reading Iron Biology
2026-09-26
Deferasirox is an oral iron chelator whose effects on iron availability can complicate ferroptosis experiments. This article connects its properties to the METTL16–SENP3–LTF findings in hepatocellular carcinoma and explains how to distinguish iron depletion from ferroptotic cell death.
-
Alfuzosin HCl Workflows for BPH Research
2026-09-25
Use Alfuzosin HCl to connect α1-adrenergic receptor pharmacology with smooth-muscle assays and gastroretentive formulation studies. This workflow combines practical solution handling, dose-ranging, release testing, and MRI-informed interpretation without treating formulation retention as proof of improved bioavailability.
-
Phosphatase Inhibitor Cocktail 1 for TLS Signaling
2026-09-25
Learn how Phosphatase Inhibitor Cocktail 1 can help preserve phosphorylation readouts when investigating B-cell signaling in tumor tertiary lymphoid structures. This article connects recent ESCC findings to practical assay choices while distinguishing sample preservation from biological pathway activation.
-
EdU Imaging Kits for ccRCC Drug-Response Studies
2026-09-24
Pair an EdU S-phase readout with sunitinib and TRIB3 perturbations to distinguish reduced DNA synthesis from changes in cell death. The HF488 click-chemistry workflow supports microscopy and flow cytometry while avoiding the DNA-denaturation step used in conventional BrdU assays.
-
Fluorinated-Sorbitol Polyplexes for mRNA Delivery
2026-09-24
This study reports a polymeric mRNA carrier that combines sorbitol functionalization to promote cellular uptake with fluorination intended to improve endosomal escape while limiting toxicity. The polyplex supported reporter expression in cells and mice, and a SARS-CoV-2 spike mRNA formulation generated neutralizing activity in a mouse vaccination study, although further validation is needed before clinical conclusions can be drawn.
-
WZ4003: NUAK1/2 Inhibitor Workflows
2026-09-23
WZ4003 provides a practical way to connect NUAK1/2 target engagement with changes in MYPT1 phosphorylation, cell behavior, and pathological tau. This workflow-focused guide covers cancer research assays, brain-slice experiments, controls, and troubleshooting for more interpretable results.